에 대한 최신 뉴스 ImmunityBio (NASDAQ:IBRX) 주식

ImmunityBio

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.

Mid Cap

News

Movers

Trading Ideas

$BTC

IBRX

IONQ

IRTC

WULF

이들 10개 중형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 이뮤니티바이오(NASDAQ:IBRX)의 주식은 회사가 재발성 B-세포 비호지킨 림프종에 대한 CAR-NK 세포 치료제의 1상 임상 연구에서 첫 환자에게 투여했다고 발표한 후 49.86% 상승했다.

트럼프 미디어와 스트라이드는 지난주 최고 성과를 보여준 10개 중형주 중 일부 (10월 21일-10월 25일)

AMKR

BILI

BRFS

ITCI

OLLI

RKLB

TALO

이들 중형주들은 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 빌리빌리(NASDAQ:BILI)의 주가는 지난주 &#39;산구오: 무딩티엔샤(San Guo: Mou Ding Tian Xia)&#39; 발표 이후 23.32% 상승했다. 또한 JP모건 애널리스트 다니엘 첸(Daniel Chen)은 중국의 빌리빌리를 중립에서 비중확대로 상향 조정하고 21달러 가격 목표를 발표했다. 

빌리빌리와 올리즈 바겐은 지난주 최대 성과를 보인 10개 중형주 중 일부 (6월 16일-6월 22일)

ImmunityBio Inc

<ul>
<li>Expands Nuclear Safety Vertical with Highly Complementary Businesses</li>
<li>Increases Geographic Footprint and Provides Entry into New Nuclear Safety Categories</li>
<li>Management Will Host a Conference Call Tomorrow at 8:30 a.m. ET to Discuss the Transaction</li>
</ul>

CDRE

Reported Earlier, Cadre Holdings To Acquire Carr's Engineering Division For £75M, Expanding Nuclear Safety Business

Palantir Technologies Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) Chief Technology Officer Shyam Sankar praised Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and SpaceX&#8217;s manufacturing approaches as models for revitalizing American industrial capabilities during an appearance on The Ben Shapiro Show on Wednesday.
What Happened: &#8220;It&#8217;s not true that we&#8217;re bad at making things in this country. The ability to do that in a modern way is asymmetrically distributed,&#8221; Sankar <a href="https://www.youtube.com/watch?v=zakFRqSJIpM">said</a>. &#8220;SpaceX makes so much of what they do vertically integrated internally. Tesla is a software-defined production line.&#8221;
His comments come as Palantir&#8217;s stock has surged over 312% in the past year, with the <a href="https://www.benzinga.com/markets/equities/25/01/42938119/lockheed-martin-donates-1m-to-trumps-inaugural-committee-as-speculation-grows-over-elon-musk-led-doge-crackdown-on-traditional-defense-contracts">company&#8217;s market capitalization</a> now exceeding traditional defense contractor Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>). The data analytics firm has been expanding beyond its government roots, with commercial revenue now representing 50% of its business.
Sankar criticized current manufacturing approaches, particularly in supply chain management. &#8220;When I interact with these companies, their understanding of their supply chain is very shallow. They treat it as a black box,&#8221; he said, contrasting this with Elon Musk&#8216;s comprehensive approach at his companies.
See Also: <a href="https://www.benzinga.com/news/25/01/43019094/bidens-farewell-address-targets-tech-oligarchy-in-trump-2-0-era-president-says-americans-face-avalanche-of-misinformation">Biden&#8217;s Farewell Address Targets Tech Oligarchy In Trump 2.0 Era: President Says Americans Face &#8216;Avalanche Of Misinformation&#8217;</a>
Why It Matters: The CTO&#8217;s remarks align with recent developments in <a href="https://www.benzinga.com/markets/equities/24/12/42356725/alex-karp-supports-doge-as-trump-taps-palantirs-shyam-shankar-for-border-security-role-cannot-have-a-better-person-than-musk">Palantir&#8217;s strategic direction</a>. CEO Alex Karp has emphasized the company&#8217;s evolution into an AI powerhouse, particularly in military applications. The company recently partnered with Amazon Web Services to provide Anthropic&#8217;s Claude AI models to U.S. intelligence agencies.
Addressing defense capabilities, Sankar highlighted concerning gaps in U.S. military readiness. &#8220;If you look at the amount of weapons we have on hand to fight China, war games put it at 8 days. It should be closer to 800 days,&#8221; he warned, citing the Ukraine conflict as evidence of production shortfalls.
Wedbush Securities analyst Dan Ives projects 2025 as a breakthrough year for Palantir&#8217;s AI platform, as the company continues to integrate advanced manufacturing and <a href="https://www.benzinga.com/markets/equities/24/12/42696805/palantir-touted-as-next-oracle-by-dan-ives-here-is-why-the-wedbush-analyst-called-the-company-a-table-pounder">artificial intelligence capabilities</a> across both government and commercial sectors.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43021065/cash-app-parent-block-inc-eyes-395-upside-bofa-believes-us-centric-re-acceleration-story-will-drive-the-stock">Jack Dorsey&#8217;s Block Eyes Over 39% Upside: BofA Says US-Centric Re-Acceleration Story Will Drive The Stock</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Equities

Markets

Tech

PLTR

TSLA

Palantir's Shyam Sankar Says SpaceX And Tesla Are Models For Reviving American Manufacturing Amid Rising Concerns Over Military Readiness

The proposed JV would be 60 per cent owned by Accenture and 40 per cent Telstra, with Telstra retaining control over its data and AI strategy and roadmap, which the JV would help deliver.

Reported Earlier, Telstra Teams Up With Accenture To Launch AI Joint Venture Supporting Data And AI Roadmap

SLXN

Reported Earlier, Silexion Therapeutics Prices Public Offering Of 3,703,703 Shares And Warrants At $1.35, Raising $5M

Reported Earlier, LG Display Reveals 4th-Gen OLED TV Panel With 40% Higher Color Brightness And 20% Energy Efficiency Gain

EV giant Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is currently offering discounts of up to $2,000 on new non-foundation series Cybertrucks listed in its U.S. inventory.
What Happened: Tesla&#8217;s website now shows multiple new non-Foundation series Cybertrucks listed with as much as a $2000 discount. The discount on demo vehicles goes up to $3,510.
A new non-foundation series Cybertruck All-Wheel Drive variant starts at $78,390 on the inventory website and a demo vehicle with 961 miles on the odometer at $77,360. 
The offers are significantly higher on the more premium Cyberbeast variant. While a demo Cyberbeast with 1,138 miles on the odometer starts at $96,480, a new vehicle starts at $97,990. 
Why It Matters: The Cybertruck is one of Tesla&#8217;s more premium offerings. The vehicle starts at $79,990 for the base all-wheel drive variant and at $99,990 for the more premium Cyberbeast variant. 
According to data from automotive research firm Kelley Blue Book, the Cybertruck was Tesla&#8217;s third best-selling vehicle in the U.S. in 2024, after its mass-market offerings Model 3 and Model Y. 
The company sold <a href="https://www.benzinga.com/25/01/42967593/cybertruck-sales-rise-in-2024-weighed-down-on-tesla-model-s-deliveries-in-us-shows-data">38,965 units in the 12 months through the end of December</a>, significantly higher than the number of Model S or Model X sold in the country. 
Until recently, Tesla listed <a href="https://www.benzinga.com/25/01/42891397/non-foundation-series-cheaper-cybertrucks-join-tesla-inventory">only foundation series Cybertrucks</a> in its inventory. The foundation series refers to a limited and pricier edition of the Cybertruck with laser-etched foundation series badges and premium accessories.
Tesla made only the foundation series Cybertrucks for the first few months of deliveries. In October, Tesla started selling the regular version of Cybertruck priced about $20,000 lower than the foundation series.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43020027/starships-7th-test-flight-postponed-to-thursday-owing-to-unfavorable-weather-says-spacex">Starship&#8217;s 7th Test Flight With Simulated Starlink Payload Delayed Until Thursday Due To Unfavorable Weather, Says SpaceX</a></li>
</ul>
Photo courtesy: Shutterstock

Tesla Offers Discounts Up To $2,000 On New Inventory Cybertrucks

A bill proposing a&nbsp;strategic&nbsp;Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reserve&nbsp;was introduced in Oklahoma on Wednesday amid a growing nationwide trend of states looking to capitalize on the apex cryptocurrency&#8217;s return potential. 
What Happened: The proposed legislation, known as House Bill 1203 or&nbsp;the Strategic Bitcoin Reserve Act,&nbsp;was <a href="https://www.okhouse.gov/posts/news-20250115_1">introduced </a>in the Oklahoma House of Representatives&nbsp;by Rep. Cody Maynard.
The bill would allow Oklahoma&#8217;s&nbsp;pension funds and state savings&nbsp;accounts to allocate a portion&nbsp;of their assets to Bitcoin, deemed a &#8220;hedge against inflation.
The State Treasurer could invest funds in any digital asset that has averaged $500 billion in market capitalization over the previous calendar year. Currently, only Bitcoin, valued at $1.97 trillion, satisfies this requirement.
Maynard stated that the assets would be managed responsibly to meet the demands of fund managers, generate reliable returns for residents, and protect purchasing power from inflationary pressures.
"Bitcoin represents freedom from bureaucrats printing away our purchasing power," the representative added. "It is the ultimate store of value for those who believe in financial freedom and sound money principles."
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/government/regulations/25/01/42994641/italys-largest-bank-leaps-into-bitcoin-trading-with-1-million-test-investment-but-ceo-says-he-doesnt-invest-in-btc-personally">Italy&#8217;s Largest Bank Leaps Into Bitcoin Trading With $1 Million &#8216;Test&#8217; Investment But CEO Says He Doesn&#8217;t Invest In BTC Personally</a>
Why It Matters: Oklahoma was not alone in this initiative. Several states have similar legislation pending, aiming&nbsp;to establish Bitcoin as a&nbsp;strategic reserve.
In November 2024,&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41986427/pennsylvania-introduces-bitcoin-strategic-reserve-act-to-invest-up-to-700-million-in-btc">Pennsylvania</a>&nbsp;introduced the Pennsylvania Bitcoin Strategic Reserve Act, which would authorize the state&#8217;s treasury to invest up to 10% of its $7 billion reserves into Bitcoin. 
A month later,&nbsp;<a href="https://www.benzinga.com/24/12/42476809/texas-joins-crypto-movement-introduces-bill-to-set-up-bitcoin-reserve">Texas</a>&nbsp;introduced a similar bill, the Texas Strategic Bitcoin Reserve Act, proposing the establishment of a special fund in the state treasury to hold Bitcoin as a financial asset for a minimum period of five years. 
Similarly, Ohio, North Dakota, and New Hampshire have introduced Bitcoin reserve bills.
Dennis Porter, founder of the Bitcoin advocacy group&nbsp;Satoshi Action Fund, which is helping formulate these bills, said that they were at the halfway mark to the goal of getting 12 states to introduce Bitcoin reserve legislation.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Oklahoma becomes the 6th state to introduce ‘Strategic Bitcoin Reserve' policy enabling the state to buy Bitcoin once passed into law. That means we are now half way to our goal of achieving 12 states to introduce SBR bills. Promises made. Promises kept. &#x1f1fa;&#x1f1f8; <a href="https://t.co/Pukr6s1Cpc">https://t.co/Pukr6s1Cpc</a>
&mdash; Dennis Porter (@Dennis_Porter_) <a href="https://twitter.com/Dennis_Porter_/status/1879598591666475347?ref_src=twsrc%5Etfw">January 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
These moves by various states reflect a growing recognition of Bitcoin as a secure state asset and a hedge against inflation, aligning with Donald Trump&#8217;s <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42434184/a-tech-renaissance-could-offer-enticing-opportunities-in-direxions-qqqu-qqqd-etfs">pledge to establish a national Bitcoin stockpile</a>.
Price Action:  At the time of writing, Bitcoin was exchanging hands at $99,745.63, up 2.77% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Image via Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/42993521/michael-saylors-microstrategy-not-alone-in-bitcoin-acquisition-says-bitwise-chief-investment-officer-its-a-bona-fide-megatrend">Michael Saylor&#8217;s MicroStrategy Not Alone In Bitcoin Acquisition, Says Bitwise Chief Investment Officer: &#8216;It&#8217;s A Bona Fide Megatrend&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

The Trump Effect? Oklahoma Joins Growing List Of States Proposing Bitcoin As Strategic Reserve Asset

Jack Dorsey&#8216;s popular Cash App digital wallet developer Block Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) is expected to deliver a strong fourth quarter given its business&#8217;s general resilience and operational excellence discipline, says <a href="https://www.benzinga.com/topic/bofa-securities">BofA Securities</a>.
The BofA Analyst: Analyst, Jason Kupferberg, maintained its &#8216;buy&#8217; rating with a price objective of $115 apiece, representing a 39.62% increase from its current price levels.
The Analyst Takeaways: Identifying its top-line growth and profitability along with its potential to contribute to the U.S.-centric re-acceleration story to the best large-caps companies, BofA analyst, Kupferberg, says it is &#8220;underappreciated&#8221; by the market.
BofA remains bullish on its dual-sided ecosystem which consists of Square, which provides technology solutions for hardware and software, and the payment application Cash App. The analyst adds that Block doesn&#8217;t have the &#8220;legacy tech&#8221; overhang as compared to some of its peers.
The Rule of 40, which is a financial metric that assesses the health of a Software-as-a-Service company is expected to be achieved by 2026, reflecting enhanced profitability focus. The rule states that the company&#8217;s gross profit growth and adjusted operating income margin should add up to at least 40%. 
Expected to report its fourth-quarter earnings on Feb. 2, BofA thinks the company&#8217;s consensus estimates are well calibrated.
Gross payment volume (GPV), an important metric to measure the payment company&#8217;s performance, is expected to grow by 8.5% to 9.1% in the fourth quarter according to BofA and consensus street estimates.
&#8220;However, given shares have outperformed since Q3 earnings, this could limit the potential for Q4 to be a significant positive catalyst,&#8221; stated the note, dated Jan. 15.
For the first quarter of the upcoming fiscal, BofA sees some GPV headwinds from the Los Angeles wildfires and likely competition from the longer February in 2024, considering the leap year.
Additionally, the company has agreed to pay $80 million to settle allegations that violated anti-money laundering laws. This could impact the first quarter as well. According to a press release, regulators in 48 states found that it failed to adequately verify customers, report suspicious activity, and implement proper controls for high-risk accounts.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42999475/amd-shares-hint-at-a-reversal-as-charts-show-bullish-stick-sandwich-following-a-double-downgrade-from-hsbc">AMD Shares Hint At A Reversal As Charts Show Bullish Stick Sandwich Following A Double Downgrade From HSBC</a> 
Price Action: Block's stock closed at $84.79 on Wednesday, reflecting a 2.88% increase. In after-hours trading, the stock rose by 1.07%. Over the past year, Block has experienced a notable growth of 30.13%.
The stock's 52-week range is between $99.26 and $55. With a market capitalization of $46,134 million, Block&#8217;s forward price-to-earnings ratio of 18.248 is lower as compared to the industry average of 81.740 and it has a relative strength index of 44.89, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Block has a consensus price target of $91.57, according to the 46 analysts <a href="https://www.benzinga.com/quote/SQ/analyst-ratings">tracked by Benzinga</a>. The high target is $120, and the low is $46. Recent ratings by Citigroup, Keefe, Bruyette &amp; Woods, and Raymond James suggest a $107.67 target, implying a 25.63% upside.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/SQ/analyst-ratings"><img loading="lazy" decoding="async" width="948" height="358" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16013900/SQ-ANR.png" alt="" class="wp-image-735979" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16013900/SQ-ANR.png 948w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16013900/SQ-ANR-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16013900/SQ-ANR-768x290.png 768w" sizes="(max-width: 948px) 100vw, 948px" /></a></figure>
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/01/43017986/warner-bros-discovery-a[…]ngth-wont-offset-joker-folie-a-deux-flop-nba-rights-concerns">Warner Bros. Discovery Analyst Says DTC Strength Won&#8217;t Offset &#8216;Joker: Folie A Deux&#8217; Flop, NBA Rights Concerns </a></li>
</ul>

Analyst Color

Market Summary

Reiteration

Analyst Ratings

General

Jack Dorsey's Block Eyes Over 39% Upside: BofA Says US-Centric Re-Acceleration Story Will Drive The Stock

Apple Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) manufacturing costs for its latest iPhone lineup show promising trends for margins, according to a new Bank of America analysis.
The teardown study reveals significant cost reductions in Pro models while highlighting the company&#8217;s strategic pricing approach across its product range.
The Apple Analyst: Bank of America analyst Wamsi Mohan maintains a &#8220;Buy&#8221; rating on Apple with a price target of $256, implying an upside of nearly 8% from Wednesday&#8217;s closing price.
The Apple Thesis: BofA&#8217;s teardown analysis reveals significant manufacturing cost improvements for iPhone 16 Pro models, while base models see increased costs.
The analyst highlights that the iPhone 16 Pro Max&#8217;s manufacturing costs are 5% lower than its predecessor, contributing approximately 320 basis points to gross margins. When adjusting for memory costs, the year-over-year savings increase to 8%.
&#8220;At Apple&#8217;s scale, these add up to meaningful savings of $3.7bn for 250mn iPhones that can be a tailwind of &gt;100 bps of product GMs when fully ramped,&#8221; noted the analysis.
See Also: <a href="https://www.benzinga.com/25/01/43019833/elon-musk-buying-tiktok-could-hurt-tesla-warns-gary-black-but-dan-ives-thinks-it-makes-sense">Elon Musk Buying TikTok Could Hurt Tesla Stock, Warns Gary Black — But Wedbush&#8217;s Dan Ives Thinks It Makes Sense</a>
Key Findings:
<ul>
<li>Main electronic assemblies make up 50% of iPhone 16 Pro Max manufacturing costs, up from 47% in the iPhone 15 Pro Max.</li>
</ul>
<ul>
<li>Base iPhone 16 shows a 10% increase in manufacturing costs compared to iPhone 15, primarily due to AI processing and camera improvements. When adjusted for memory costs, this increase narrows to 6%.</li>
</ul>
<ul>
<li>Potential savings of at least $10 per iPhone from insourcing the baseband modem from Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>).</li>
</ul>
<ul>
<li>Vertical integration efforts could drive further margin improvements. The company spends approximately $250 on integrated circuits per iPhone 16 Pro Max, creating opportunities for cost savings through component insourcing.</li>
</ul>
Why It Matters: The findings support BofA&#8217;s broader thesis on Apple&#8217;s margin resilience. The bank expects strong iPhone upgrade cycles in fiscal 2025 and 2026, driven by hardware requirements for generative AI features.
Apple&#8217;s gross margins have been trending higher in the last several years, supported by both services mix and iPhone margin stability despite increased functionality.
Trading at $237.87, Apple shares have gained nearly 30% over the past year. Apple is set to announce its first-quarter 2025 earnings on Jan. 30. In October last year, the company reported fiscal <a href="https://www.benzinga.com/news/earnings/24/10/41666494/apple-q4-earnings-revenue-beat-eps-beat-installed-base-hits-new-highs-iphone-sales-rise-as-apple-in">fourth-quarter revenue</a> of $94.9 billion, surpassing analysts&#8217; expectations of $94.56 billion.
Price Action: Apple&#8217;s stock gained 1.97% on Wednesday, closing at $237.87. In after-hours trading, it edged up another 0.31%, reaching $238.60, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Apple&#8217;s consensus price target stands at $245.17, based on evaluations from 30 analysts, with Wedbush setting the highest target of $325 on Dec. 26. The latest ratings from MoffettNathanson, Bernstein, and BofA Securities point to an average target of $234.67, implying a potential downside of 1.65%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/AAPL/analyst-ratings"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/16002414/Screenshot-2025-01-16-at-10.54.09%E2%80%AFAM-1024x376.png" alt="" class="wp-image-735922" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43018848/those-are-air-bubbles-the-time-steve-jobs-rejected-the-first-ipod-prototype-and-pushed-apple-engineers-to-think-smaller" target="_blank" rel="noreferrer noopener">Steve Jobs Dropped The First iPod Prototype In A Fish Tank And It Wasn't To Test If It Was Waterproof</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

AAPL

QCOM

Apple Stock Has Moved Up 4.2% Since iPhone 16 Launched, Analyst Says It Has Another 8% Upside As Manufacturing Cost Decline Bolsters Cupertino's Margins

President-elect&nbsp;Donald Trump&nbsp;has nominated&nbsp;Scott Bessent&nbsp;to lead the U.S. Treasury Department, and Bessent has pledged to maintain the dollar&#8217;s status as the world&#8217;s reserve currency. This commitment was made during his prepared testimony.
What Happened: Bessent, who is scheduled to appear&nbsp;before the U.S. Senate Finance&nbsp;Committee on Thursday, emphasized the importance of prioritizing productive investment over &#8220;wasteful spending&#8221; that could lead to inflation. He stressed the need to secure supply chains and carefully use sanctions to meet national security needs, Reuters&nbsp;reported on Wednesday.
&#8220;And critically, we must ensure that the U.S. dollar remains the world&#8217;s reserve currency,&#8221; he said.
Additionally,&nbsp;Bessent, a hedge fund manager, has supported Trump&#8217;s plans for higher tariffs on imports, although he did not mention China specifically in his remarks. Trump has previously threatened significant tariffs on imports from China, Canada, and Mexico.
Bessent also highlighted the necessity for Congress to make permanent the provisions of Trump&#8217;s 2017 Tax Cuts and Jobs Act. He warned that failing to do so could result in a historic $4 trillion tax increase. He advocated for &#8220;pro-growth policies&#8221; to reduce the tax burden on American manufacturers, service workers, and seniors.
Bessent comments come at a time when Trump is<a href="https://www.benzinga.com/25/01/42779917/trump-wont-announce-strategic-bitcoin-reserve-via-executive-order-says-analyst-he-would-likely-buy-btc-in-the-background"> reportedly exploring the possibility</a> of issuing an executive order to create a Strategic Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) Reserve (SBR). After providing substantial financial support during the 2024 election, the digital asset industry is <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42701446/crypto-industry-anticipates-policy-overhaul-under-trump-administration">gearing up for a major shift in its regulatory landscape</a>. President-elect Trump, once a vocal critic of digital currencies, shifted his stance during his campaign, becoming the first presidential candidate to accept donations in digital assets.
Why It Matters: Bessent&#8217;s nomination comes at a time when the dollar&#8217;s role as the <a href="https://www.benzinga.com/25/01/43019785/trump-treasury-nominee-pledges-to-maintain-dollars-global-reserve-status-outlines-vision-for-new-economic-golden-age">global reserve currency </a>is under scrutiny. His commitment to maintaining this status aligns with his vision for a &#8220;new economic golden age,&#8221; as outlined in his testimony. 
Meanwhile, Bessent&#8217;s <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42936887/trumps-treasury-pick-scott-bessent-reveals-up-to-500000-bitcoin-stake-via-blackrocks-etf">financial disclosures reveal</a> a significant stake in the&nbsp;iShares Bitcoin Trust ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>), indicating his interest in cryptocurrencies amid expectations of crypto-friendly policies under the incoming Trump administration.
Read Also: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42995814/billionaire-investor-who-predicted-the-dot-com-crash-25-years-ago-warns-of-another-market-storm-brewing-in-the-us">Billionaire Investor Who Predicted The Dot-Com Crash 25 Years Ago Warns Of Another Market Storm Brewing In The US</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Wikimedia Commons

Macro Economic Events

Economics

IBIT

Trump's Treasury Pick Scott Bessent Urges Dollar Must Remain 'World's Reserve Currency' As President-Elect Reportedly Pushes For Strategic Bitcoin Reserve

Econ #s

Germany Consumer Price Index (YoY) For December 2.6% Vs. 2.6% Est.; 2.2% Prior

Germany Consumer Price Index (MoM) For December 0.5% Vs. 0.4% Est.; -0.2% Prior

U.K. Trade Balance Non-EU For November -7.72B Vs. -7.65B (Revised) Prior

U.K. Trade Balance For November -19.31B Vs. -18.00B Est.; -19.33B (Revised) Prior

U.K. Monthly Gross Domestic Product (GDP) 3M/3M Change For November 0.0% Vs. 0.0% Est.; 0.0% (Revised) Prior

U.K. Manufacturing Production (MoM) For November -0.3% Vs. -0.2% Est.; -0.6% Prior

U.K. Industrial Production (MoM) For November -0.4% Vs. 0.1% Est.; -0.6% Prior

U.K. Gross Domestic Product (MoM) For November 0.1% Vs. 0.2% Est.; -0.1% Prior

IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) and&nbsp;L'Oréal, the world's leading beauty company, announced a collaboration to leverage <a href="https://www.ibm.com/think/topics/generative-ai">IBM's generative artificial intelligence (GenAI)</a> technology and expertise to uncover new insights in cosmetic formulation data, facilitating L'Oréal's&nbsp;use of sustainable raw materials, for energy and material waste reductions. This unique effort will develop a custom AI foundation model engineered to significantly increase the ability of L'Oréal Research &amp; Innovation teams to reach extra performance and consumer satisfaction in every cosmetic category and every region of the world. The formulation foundation model is believed to be a&nbsp;first-of-its-kind in the industry, redefining AI innovation at the intersection of beauty, chemistry and technology.&nbsp;

IBM and L'Oréal Partner to Develop AI for Sustainable Cosmetic Formulations

Pan American Silver Corp. &nbsp;achieved its production guidance for 2024, with 21.1 million ounces of silver and 892 thousand ounces of gold produced in 2024. Guidance was also achieved for annual production of zinc, lead and copper.
The full-year ("FY 2024") production results were driven by strong performance in the fourth quarter 2024 ("Q4 2024"):
<ul>
<li>Silver production of 6.0 million ounces in Q4 2024, with the La Colorada mine in Mexico making a significant contribution, producing 1.6 million ounces of silver in the quarter.</li>
<li>Gold production of 224 thousand ounces in Q4 2024, which excludes December production from the La Arena mine in Peru, the sale of which was completed on December 2, 2024, as previously announced by the Company.</li>
</ul>

PAAS

Reported Earlier, Pan American Silver Achieves 2024 Production Targets With 21.1M Ounces Silver And 892K Ounces Gold, Ends Year With $887.3M Cash

ImmunityBio announces proposed public offering of common stock

ImmunityBio (IBRX) announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritt...

ImmunityBio announces common stock offering, no amount given

ImmunityBio stock plummets on announcing common stock offering

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Albertsons (ACI) terminated its merger...

Albertsons terminates Kroger deal, Macy's reports Q3 beat: Morning Buzz

ImmunityBio's Cash Burn And Dilution Dampen Anktiva's Potential

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Adobe (ADBE) reported better-than-expe...

Adobe outlook disappoints, Kroger announces $7.5B buyback: Morning Buzz

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Broadcom (AVGO) jumped as enthusiasm a...

Broadcom tops $1T market cap on AI enthusiasm: Morning Buzz

ImmunityBio: Despite Share Price & Funding Woes, Muddy Path To Long-Term Success

ImmunityBio: Forging A New Plan After Recent $100 Million Offering

A First Take On CG Oncology

ADBE

AFRM

AMZN

ANAB

ANIP

AVGO

BLCO

CADL

CGNT

CGON

CHTR

CIEN

CMCSA

COST

ELVA

ENGN

EVGO

FIGS

HNDAF

KVUE

LOVE

MDLZ

NDSN

NFLX

NVDA

PDCO

PENN

PLAY

REVG

SCHW

SFIX

SIRI

SNYNF

SSNLF

TASK

TMUS

ULCC

VWAGY

VWAPY

Small Cap

Opinion

Press Releases

Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon

ImmunityBio Completes ANKTIVA's Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months

ImmunityBio, Inc. Investor Alert (NASDAQ: IBRX): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements

ImmunityBio and nCartes Enter Collaboration Agreement on Clinical Trial Data Fulfillment

ImmunityBio, Inc. Announces Proposed Public Offering of Common Stock

ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock

D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering

ImmunityBio Announces Permanent J-code (J9028) for ANKTIVA® Is Now Effective

ImmunityBio Provides Regulatory Update on Anticipated FDA Submissions in 2025 Following Meeting with the Agency

ImmunityBio Provides Regulatory Update on Global Submission for ANKTIVA + BCG in BCG Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ in Europe and United Kingdom

IOVA

ONCY

SNDX

SWTX

TSX:ONC

Agios Pharmaceuticals, Inc. - Common Stock

Agios Pharmaceuticals

Akero Therapeutics

Arcutis Biotherapeutics, Inc. - Common stock

Arcutis Biotherapeutics

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Beam Therapeutics

CG Oncology

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Centessa Pharmaceuticals plc - American Depositary Shares

Centessa Pharmaceuticals

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Dyne Therapeutics

Geron

Galapagos NV - American Depositary Shares

Galapagos

IDEAYA Biosciences

Immunocore Holdings plc - American Depositary Shares

Immunocore Hldgs

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Disc Medicine

Mesoblast Limited - American Depositary Shares

Mesoblast

Mirum Pharmaceuticals, Inc. - common stock

Mirum Pharmaceuticals

MannKind

Novavax

Protagonist Therapeutics, Inc. - Common Stock

Protagonist Therapeutics

Soleno Therapeutics

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Vir Biotechnology

Xencor

BTIG

D. Boral Capital

EF Hutton

Piper Sandler

Jefferies

이들 10개 중형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 이뮤니티바이오(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>)의 주식은 회사가 재발성 <a href="https://www.benzinga.com//node/41516867" target="_blank" rel="noreferrer noopener">B-세포 비호지킨 림프종</a>에 대한 CAR-NK 세포 치료제의 1상 임상 연구에서 첫 환자에게 투여했다고 발표한 후 49.86% 상승했다.
2. 스트라이드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>)의 주식은 회사가 1분기 실적이 예상보다 좋게 나타났고, 2025 회계연도 및 2분기 <a href="https://www.benzinga.com//node/41487340" target="_blank" rel="noreferrer noopener">매출 가이던스도 예상치를 상회</a>했다고 발표한 후 41.43% 급등했다. 애널리스트들이 <a href="https://www.benzinga.com/quote/lrn/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 목표</a>를 올렸다.
3. 퓨어사이클 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>)의 <a href="https://www.benzinga.com//node/41409452" target="_blank" rel="noreferrer noopener">주식은 32.21% 상승</a>했다.
4. 트럼프 미디어 앤 테크놀로지 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>)의 주식은 지난주에 31.68% 상승했다. 이 주식은 다가오는 미국 선거를 앞두고 변동성을 보였다.
5. 지커 인텔리전트 테크놀러지(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZK#NYSE">ZK</a>)의 주식은 29.31% 상승했다. 여러 미국 상장 중국 주식들이 인민은행이 <a href="https://www.benzinga.com//node/41547149" target="_blank" rel="noreferrer noopener">7,000억 위안</a> (약 983억 6천만 달러)를 은행 시스템에 주입하고 금리를 2.0%로 유지했다고 발표한 후 상승했다.
6. 아이온큐(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>)의 주식은 27.52% 상승했다.
7. 허크 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRI#NYSE">HRI</a>)의 주식은 회사가 3분기 매출 실적이 예상보다 좋았고 2024 회계연도 장비 <a href="https://www.benzinga.com//node/41455862" target="_blank" rel="noreferrer noopener">임대 매출 성장 전망을 상향 조정</a>했다고 발표한 후 21.76% 상승했다.
8. 테라울프(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>)의 주식은 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) 가격 상승으로 18.59% 상승했다. 이 회사는 또한 4억 2,500만 달러를 전환사채로 조달할 것을 제안했다.
9. 아이리듬 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/41462205" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">지오(Zio) AT 기기</a>의 이전 설계 변경과 관련된 510(k) 제출에 대해 FDA 승인을 받았다고 발표한 후 주가가 20.76% 상승했다.
10. 셀레스티카(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>)의 주식은 회사가 3분기 실적이 예상보다 좋았고 4분기 매출 가이던스를 예상치를 상회한다고 발표한 후 19.99% 상승했다. 여러 애널리스트들이 <a href="https://www.benzinga.com//node/41523564" target="_blank" rel="noreferrer noopener">주가 목표</a>를 올렸다.
또한 읽어보기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%ED%85%8C%EC%8A%AC%EB%9D%BC%EC%99%80-%EB%A6%AC-%EC%98%A4%ED%86%A0%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%97%AC%EC%A4%80-10%EA%B0%9C-%EB%8C%80/" target="_blank" rel="noopener">테슬라와 리 오토는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (10월 21일-10월 25일)</a></li>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%A0%9C%EB%89%B4%EC%9D%B8-%ED%8C%8C%EC%B8%A0-%EB%B0%8F-%ED%83%91%EB%B9%8C%EB%93%9C%EA%B0%80-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EC%95%85%EC%9D%98-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%9D%B8-10/" target="_blank" rel="noopener">제뉴인 파츠 및 탑빌드가 지난주 최악의 성과를 보인 10개 대형주 중 일부 (10월 21일-10월 25일)</a></li>
</ul>
Photo via Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이들 중형주들은 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
<ol>
<li>빌리빌리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>)의 주가는 지난주 &#8216;산구오: 무딩티엔샤(San Guo: Mou Ding Tian Xia)&#8217; 발표 이후 23.32% 상승했다. 또한 JP모건 애널리스트 다니엘 첸(Daniel Chen)은 중국의 빌리빌리를 중립에서 비중확대로 상향 조정하고 <a href="https://www.benzinga.com//node/39418621" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">21</a>달러 가격 목표를 발표했다.</li>
<li>이뮤니티바이오(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>)의 주가는 안크티바(ANKTIVA)가 여러 주에 걸쳐 <a href="https://www.benzinga.com//node/39417764" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">첫 번째 상용 투여량</a>을 투여한 보험 적용 범위를 발표한 이후 지속적인 강세로 22.36% 상승했다.</li>
<li>사솔(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSL#NYSE">SSL</a>)은 회사가 법원에서 회사와 토탈에너지스 SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) 마켓팅에 유리한 판결을 내렸다고 발표한 후 주가는 20.89% 상승했다. 또한 손해배상금으로 38.9억 랜드, <a href="https://www.benzinga.com//node/39412202" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">이자로 약 2,300만 랜드</a>를 받았다.</li>
<li>지난주 올리즈 바겐 아울렛 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>)의 주식은 JP모건이 중립에서 <a href="https://www.benzinga.com/quote/OLLI/analyst-ratings">비중확대</a>로 평가를 올린 이후 15.25% 상승했다.</li>
<li>인트라-셀룰러 테라피스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>)는 회사가 루마테페론을 주요 우울 장애 환자를 위한 보조 요법으로 평가하고 <a href="https://www.benzinga.com//node/39382029" target="_blank" rel="noreferrer noopener">1차 및 주요 2차 평가변수를 충족</a>시키는 두 번째 3상 시험의 톱라인 결과를 발표한 후 주가는 13.18% 상승했다.      shares advanced 12.06% on overall strength in chip stocks. Also, B. Riley Securities analyst <a href="https://www.benzinga.com/quote/AMKR/analyst-ratings" target="_blank" rel="noopener">raised the price forecast</a> on the stock from $45 to $50.</li>
<li>앰코 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>)는 전반적인 칩주 강세로 주가는 12.06% 상승했다. 또한 B. 라일리 증권(B. Riley Securities)의 분석가는 주식 가격 <a href="https://www.benzinga.com/quote/AMKR/analyst-ratings" target="_blank" rel="noopener">예측</a>을 45달러에서 50달러로 높였다.</li>
<li>아이리듬 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>)는 회사가 이전에 공개한 <a href="https://www.benzinga.com//node/39411935" target="_blank" rel="noreferrer noopener">제조 자동화 계획</a>의 초기 단계를 시작한 후 기업의 이정표에 도달했다고 발표한 후 주가는 11.53% 증가했다.</li>
<li>로켓 랩 USA(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>)는 주가는 <a href="https://www.benzinga.com//node/39429411" target="_blank" rel="noreferrer noopener">일본 기업 신스펙티브(Synspective)</a>와 도쿄에서 10개 제품 출시 계약을 체결한 후 11.32% 상승했다.</li>
<li>브레드 파이낸셜 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFH#NYSE">BFH</a>)는 에버코어 ISI 그룹(Evercore ISI Group)이 이 주식을 언더퍼폼(Underperform)에서 인-라인(In-Line)으로 평가를 올리고 목표 주가를 42달러에서 45달러로 <a href="https://www.benzinga.com/quote/BFH/analyst-ratings" target="_blank" rel="noreferrer noopener">상향 조정한 </a>이후 10.81% 상승했다. 또한 또한 RBC 캐피털은 해당 주식에 대해 섹터 퍼폼(Sector Perform) 등급을 유지하고 목표 주가를 38달러에서 45달러로 높였다.</li>
<li>BRF S.A.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRFS#NYSE">BRFS</a>)의 주식은 10.69% 상승했다.</li>
</ol>
위키미디어 커먼즈를 통한 사진
기사 읽기: <a href="https://kr.benzinga.com/news/%ea%b2%8c%ec%9e%84%ec%8a%a4%ed%83%91%ea%b3%bc-%ec%9e%90%eb%b9%8c%ec%9d%80-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ec%95%85%ec%9d%98-%ec%84%b1%ea%b3%bc%eb%a5%bc-%eb%b3%b4%ec%9d%b8-10%ea%b0%9c%ec%9d%98/" target="_blank" rel="noopener">게임스탑과 자빌은 지난주 최악의 성과를 보인 10개의 대형주 중 일부 (6월 16일-6월 22일)</a>

Comments

ImmunityBio

뉴스

에 대한 최신 뉴스 ImmunityBio (NASDAQ:IBRX) 주식

월요일, 10월 28, 2024

월요일, 6월 24, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌